Literature DB >> 20502889

Individual off-label use needs to be replaced by controlled studies.

Joachim Berkefeld1, Jens Fiehler.   

Abstract

Mesh：

Year:  2010        PMID： 20502889     DOI： 10.1007/s00234-010-0706-5

Source DB:  PubMed          Journal:  Neuroradiology        ISSN： 0028-3940            Impact factor:   2.804


× No keyword cloud information.
  3 in total

1.  [Regulatory aspects of clinical trials for medical devices and in vitro diagnostics].

Authors:  J A Schwarz
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2005-05       Impact factor: 1.513

Review 2.  Statistical and regulatory issues in nonrandomized medical device clinical studies.

Authors:  Heng Li; Lilly Q Yue
Journal:  J Biopharm Stat       Date:  2008       Impact factor: 1.051

3.  HydroCoil for Endovascular Aneurysm Occlusion (HEAL) study: periprocedural results.

Authors:  H J Cloft
Journal:  AJNR Am J Neuroradiol       Date:  2006-02       Impact factor: 3.825
  3 in total
  1 in total

1.  The issue of whether studies involving off-label use of new devices need to be replaced by controlled studies.

Authors:  Hans Henkes
Journal:  Neuroradiology       Date:  2010-09-04       Impact factor: 2.804
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.